SANDBERGS GULDSMEDJE ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  6.6% 6.5% 4.8% 13.0% 19.0%  
Credit score (0-100)  38 38 46 18 6  
Credit rating  BBB BBB BBB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12

Net sales  0 0 0 0 0  
Gross profit  220 231 291 331 51.9  
EBITDA  73.8 84.2 144 97.8 51.9  
EBIT  73.8 84.2 144 97.8 51.9  
Pre-tax profit (PTP)  77.4 84.2 144.3 96.5 50.4  
Net earnings  60.1 65.4 111.8 74.1 39.1  
Pre-tax profit without non-rec. items  77.4 84.2 144 96.5 50.4  

 
See the entire income statement

Balance sheet (kDKK) 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  198 157 237 199 125  
Interest-bearing liabilities  11.7 1.7 1.6 6.5 0.3  
Balance sheet total (assets)  330 216 385 319 155  

Net Debt  -154 -45.7 -169 -313 -153  
 
See the entire balance sheet

Volume 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  220 231 291 331 51.9  
Gross profit growth  37.4% 4.7% 26.1% 13.8% -84.3%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  330 216 385 319 155  
Balance sheet change%  0.5% -34.8% 78.5% -17.0% -51.5%  
Added value  73.8 84.2 144.4 97.8 51.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 5.0  

Profitability 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  33.5% 36.5% 49.6% 29.5% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  23.5% 30.8% 48.1% 27.8% 21.9%  
ROI %  32.6% 45.7% 72.7% 44.1% 31.4%  
ROE %  27.4% 36.8% 56.7% 34.0% 24.1%  

Solidity 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Equity ratio %  59.8% 73.0% 61.6% 62.4% 80.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -208.2% -54.3% -117.3% -319.7% -294.9%  
Gearing %  5.9% 1.1% 0.7% 3.3% 0.2%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 6.7% 32.4% 44.6%  

Liquidity 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Quick Ratio  1.5 1.7 1.6 2.7 5.2  
Current Ratio  2.5 3.7 2.6 2.7 5.2  
Cash and cash equivalent  165.2 47.4 171.1 319.4 153.4  

Capital use efficiency 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  197.7 157.3 236.8 199.1 125.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
Net sales / employee  0 0 0 0 0  
Added value / employee  74 84 144 98 52  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  74 84 144 98 52  
EBIT / employee  74 84 144 98 52  
Net earnings / employee  60 65 112 74 39